Clinical Observation on Jianpi Liqi Recipe for Treatment of 25 Cases of Distal Metastasis of Liver Cancer

doi:10.13288/j.11-2166/r.2005.01.015

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on Jianpi Liqi Recipe for Treatment of 25 Cases of Distal Metastasis of Liver Cancer

更新时间：2021-11-20

- Clinical Observation on Jianpi Liqi Recipe for Treatment of 25 Cases of Distal Metastasis of Liver Cancer
- Journal of Traditional Chinese Medicine Issue 1, Pages: 26-28(2005)
- 作者机构：
  
  1. 上海复旦大学肿瘤医院中医科
  2. 上海第二医科大学新华医院肿瘤科上海市东安路270号,200032
  3. 上海复旦大学肿瘤医院中医科上海第二医科大学新华医院肿瘤科上海市东安路270号,200032
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2005.01.015
  CLC： R735.7
- Published：2005
- 稿件说明：
移动端阅览
[1]林钧华,郭伟剑.健脾理气方联合介入疗法治疗肝癌远处转移25例临床观察[J].中医杂志,2005(01):26-28.

Clinical Observation on Jianpi Liqi Recipe for Treatment of 25 Cases of Distal Metastasis of Liver Cancer[J]. Journal of Traditional Chinese Medicine2005, (1): 26-28.
[1]林钧华,郭伟剑.健脾理气方联合介入疗法治疗肝癌远处转移25例临床观察[J].中医杂志,2005(01):26-28. DOI： 10.13288/j.11-2166/r.2005.01.015.

Clinical Observation on Jianpi Liqi Recipe for Treatment of 25 Cases of Distal Metastasis of Liver Cancer[J]. Journal of Traditional Chinese Medicine2005, (1): 26-28. DOI： 10.13288/j.11-2166/r.2005.01.015.

摘要

目的:观察健脾理气中药对肝癌肝动脉化疗栓塞（TACE）促转移的干预作用。方法:50例原发性肝癌随机分为 TACE组和 TACE+健脾理气方组

于 TACE 前后测定血清血管内皮细胞生长因子（VEGF）水平

观察生存率和远处转移率。结果:TACE 治疗前后及两组间 VEGF 差异无显著性（P>0.05）

TACE 组1、2年生存率分别为76%、40%

TACE+健脾理气方组1、2年生存率分别为72%、64%

两组2年生存率差异有显著性（P<0.01）。两组1、2年远处转移率分别为28%、52%和8%、24%

2年远处转移率差异有显著性（P<0.05）。结论:健脾理气中药对 TACE 促肝癌转移有一定的阻断作用

但 TACE 后短期内并未明显抑制 VEGF 的表达。

Abstract

Objective:To observe interfering action of Chinese drugs for strengthening spleen and regulating Qi on promoting metastasis of transcatheter arterial chemoemboization（TACE）of liver cancer.Methods:50 cases of primary cancer of liver were randomly divided into TACE group and TACE plus Jianpi Liqi Recipe group

and serum vascular endothelial growth factor（VEGF）level before and after TACE was determined and the survival rate and the distal metastasis rate were observed.Results:There was no significant differences before and after TACE

and between the two groups（P>0.05）.The survival rates of 1 and 2 years were 76%and 40% in TACE group

and 72% and 64% in TACE plus Jianpi Liqi Recipe group

respectively.There was a significant difference between the two groups in the survival rate of 2 years（P<0.01）.The distal metastasis rates of 1 and 2 years were 28%

52%

and 8%

24% in the two groups with a significant difference in the distal metastasis of 2 years between the two groups（P<0.05）.Conclusion:The drug for strengthening spleen and regulating Qi has a certain blocking action on TACE promoting metastasis of liver cancer

but TACE does not obviously inhibit depression of VEGF within a sort term.

关键词

Keywords

references

查看原文

Views

141

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Study on Chinese Medicine Combined with Chemotherapy for Treatment of 32 Cases of Advanced Pancreatic Cancer

Clinical Therapeutic Effect of Chinese Drug Combined with Interventional Therapy on 33 Cases of Cardiac Carcinoma

The Philosophy and Practical Pathway of "Dao （道）-Shen （神）-Formula" in Traditional Chinese Medicine

Efficacy and Economic Evaluation of Weishi Qingjin Formula （苇石清金方）in the Treatment of Adult Community-Acquired Pneumonia with Phlegm-Heat Obstructing the Lung Syndrome：A Multicenter Retrospective Real-World Cohort Study

Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"

Related Author

Shen Yehua

Liu Luming

Chen Zhen

et al.

宋明志

于尔辛

苑静波

苏春芝

Related Institution

Cancer Hospital,Fudan University

复旦大学附属肿瘤医院中医科上海市东安路270号

河北省中医院

河北省优抚医院

石家庄铁路中心医院石家庄市中山东路389号

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰